Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (BST:08HH)

Market Cap	7.49B +7.9%
Revenue (ttm)	5.32B +4.9%
Net Income	437.16M +18.9%
EPS	0.16 +19.4%
Shares Out	n/a
PE Ratio	17.13
Forward PE	18.12
Dividend	0.04 (1.92%)
Ex-Dividend Date	Jul 24, 2025

Volume	n/a
Average Volume	850
Open	1.904
Previous Close	1.933
Day's Range	1.901 - 1.941
52-Week Range	1.806 - 3.042
Beta	n/a
RSI	32.77
Earnings Date	Apr 28, 2026

About BST:08HH

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, car...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40,603
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 08HH

Financial Performance

In 2025, BST:08HH's revenue was 41.66 billion, an increase of 1.45% compared to the previous year's 41.07 billion. Earnings were 3.37 billion, an increase of 21.69%.

Financial numbers in CNY